Compare ZG & IBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZG | IBRX |
|---|---|---|
| Founded | 2004 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.4B | 8.2B |
| IPO Year | 2014 | 2015 |
| Metric | ZG | IBRX |
|---|---|---|
| Price | $36.82 | $7.92 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 25 | 7 |
| Target Price | ★ $78.68 | $12.57 |
| AVG Volume (30 Days) | 1.4M | ★ 8.5M |
| Earning Date | 05-06-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 118.75 | 38.71 |
| EPS | ★ 0.18 | N/A |
| Revenue | ★ $1,076,794,000.00 | $113,288,000.00 |
| Revenue This Year | $17.77 | $88.59 |
| Revenue Next Year | $13.31 | $131.15 |
| P/E Ratio | $208.00 | ★ N/A |
| Revenue Growth | 27.19 | ★ 668.31 |
| 52 Week Low | $29.03 | $1.95 |
| 52 Week High | $90.22 | $12.43 |
| Indicator | ZG | IBRX |
|---|---|---|
| Relative Strength Index (RSI) | 57.48 | 55.13 |
| Support Level | $35.11 | $7.77 |
| Resistance Level | $37.59 | $8.46 |
| Average True Range (ATR) | 1.80 | 0.33 |
| MACD | 0.22 | 0.09 |
| Stochastic Oscillator | 79.35 | 78.66 |
Zillow Group Inc is a real estate technology company offering a digital platform that connects real estate customers with sellers, agents, loan officers, and other real estate-related professionals. With its tools and resources, Zillow helps real estate professionals grow their businesses, and for renters and housing providers, it offers a marketplace along with a set of end-to-end products and services to streamline applications, leases, payments, and more. The group operates various brands such as Zillow, Zillow Home Loans, Zillow Rentals, Zillow New Construction, Trulia, StreetEasy, Out East, HotPads, Follow Up Boss, ShowingTime, dotloop, and Zillow Closing. Its ecosystem spans the entire home journey from shopping to renting, buying, selling, and financing real estate.
ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.